A new approach to preventing and reducing the adverse effects of medications in people with mental illnesses will utilize personalized medicine to manage drug therapy by analyze each patient’s genetic makeup to determine potential adverse reactions to medications. This new initiative is funded by the Polk Foundation, and led by NHS Human Services in collaboration with geneticists at the University of Pittsburgh Graduate School of Public Health.
“Individuals can suffer immensely from the very drugs that are meant to improve their health if given drugs they cannot tolerate, often resulting in increased emergency room visits and elevated health care costs,” said Dietrich Stephan, Ph.D., professor and chair of the Department of Human Genetics at Pitt Public Health. “The people at highest risk, such as the aged and mentally ill, often are prescribed a multitude of drugs with no insight into their genetic susceptibilities.”
http://www.prweb.com/releases/2015/02/prweb12488394.htm
“Individuals can suffer immensely from the very drugs that are meant to improve their health if given drugs they cannot tolerate, often resulting in increased emergency room visits and elevated health care costs,” said Dietrich Stephan, Ph.D., professor and chair of the Department of Human Genetics at Pitt Public Health. “The people at highest risk, such as the aged and mentally ill, often are prescribed a multitude of drugs with no insight into their genetic susceptibilities.”
http://www.prweb.com/releases/2015/02/prweb12488394.htm
RSS Feed
